The Patvocates team strives to deliver best value in the area of patient advocacy and patient engagement services. To complement our expertise and knowledge and to enhance our footprint, we are partnering with the following organisations:

The US-based consultancy Rx4good shares our mission, passion and expertise for patient advocacy by empowering healthcare organizations to deliver on their promise to put patients first. Together we are implementing transcontinental projects for companies, government, academia and nonprofits, in order to make the patient more integral to day-to-day decision-making. Rx4good is Patvocates’ preferred partner on advocacy-driven consultancy in the USA, while we work with Rx4good on implementing projects in a very diverse and heterogeneous Europe.

European Patient Advocacy Institute (EPAI)

The European Patient Advocacy Institute (EPAI), established as a charitable institution in Germany in 2017, acts as a patient-led education and research platform to strengthen patient advocacy, patient involvement and evidence generation in patient advocacy, research, health policy and healthcare services. As the non-profit sister organisation of Patvocates, it spearheads several impactful initiatives aimed at enhancing patient advocacy, research, and healthcare delivery across Europe, and hosts various networks and patient organisations which do not have their legal entity yet.

EPAI engages with patient advocacy organisations and other healthcare stakeholders to drive change. EPAI’s collaborations encompass a range of networks and initiatives that share our commitment to patient-centred care.

Patvocates strongly promotes the engagement values, the guidance and the educational tools developed by EUPATI. By developing and holding trainings and workshops, it supports patient organisations and research organisations to adopt and use the EUPATI material and methodologies. We are involving patient community members trained by EUPATI on the European and national level in our projects to make sure strong, knowledgeable patient advocates are partners and contributors in those activities. Patvocates donates a percentage of its revenue to EUPATI to support patient education.

The open, independent global collaborative platform Patient Focused Medicines Development (PFMD) aims to transform how we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs. PFMD is bringing together and synergizing disparate but complementary efforts that integrate the voice of the patient across the lifecycle of medicine, e.g. by developing co-designed key tools and methodologies in patient engagement. Patvocates team members have been involved in PFMD since its initiation to co-create PFMD’s frameworks and tools.